Acrivon TherapeuticsACRV

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. Peter Blume-Jensen, M.D.,PhD

$250.4M

Market Cap • 23/05/2024

2018

(há 6 anos)
Fundação

2022

(2 years ago)
IPO

NASDAQ

Listagem
Flag of US

Watertown

Sede • Massachusetts

44

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

ACRVSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-5%

1 dia

20/05/2024

-5%

1 semana

16/05/2024

-17%

1 mês

23/04/2024

-34%

1 ano

23/05/2023

10 anos

Histórico